Wearable sleeve comes closer to commercialization
SleeveSense is a wearable vitals monitor.
Senphonix
A wearable device developed at the University of Arizona was featured in Today's Medical Developments. The device, called SleeveSense, will be sold by medtech startup Senphonix and is expected to hit the market in 2027.
SleeveSense is a mesh sleeve outfitted with sensors that measure vital signs in real time. The device is designed to help nurses closely track patient health while reducing their workload to enable better care. Philipp Gutruf, associate professor and associate department head of biomedical engineering, is the primary inventor of SleeveSense. Senphonix licensed the technology and is working with Gutruf to ensure the device is accurate and comfortable enough for patients to wear continuously for days, weeks or months.
“It’s been an amazing experience so far,” said Senphonix co-founder and co-CEO Mike Haldane. “We’re working with the university to do the design work and to put their intellectual property into a commercial state, which is great for them, and it’s great for us."